Kolexia
Paoli Jean-Baptiste Oncologie radiothérapie
Paoli Jean-Baptiste
Oncologie radiothérapie
Clinique Chirurgicale De Martigues
Martigues, France
56 Activités
854 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Tumeurs de la prostate Tumeurs prostatiques résistantes à la castration Carcinome pulmonaire à petites cellules {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Foa Cyril
Foa Cyril
Clinique Chirurgicale De Martigues, Martigues, France
Ducournau Aurelie
Ducournau Aurelie
Clinique Chirurgicale De Martigues, Martigues, France
Gross Emmanuel
Gross Emmanuel
Clinique Chirurgicale De Martigues, Martigues, France
Escarguel Bruno
Escarguel Bruno
Cabinet libéral, Marseille, France

Industries

Voir plus
AstraZeneca
10 collaboration(s)
Dernière en 2023
MSD
8 collaboration(s)
Dernière en 2023
Sanofi
6 collaboration(s)
Dernière en 2023
Amgen
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
DUART: A Phase II, Open-label, Multicenter, International Study of Durvalumab Following Radiation Therapy in Patients With Stage III, Unresectable Non-Small Cell Lung Cancer Who Are Ineligible for Chemotherapy
Essai Clinique (AstraZeneca)   05 janvier 2024
LUCIOLA: Evaluation of the Performance and Tolerance of the NOVATECH ® LUCIOLA TM EB Fiducial Marker During Radiotherapy Sessions in Patients Suffering From Lung Cancer: Multicenter, Post CE-mark Study
Essai Clinique (Novatech)   26 janvier 2023
Two-year update from KEYNOTE-799: Pembrolizumab plus concurrent chemoradiation therapy (cCRT) for unresectable, locally advanced, stage III NSCLC.
2022 ASCO Annual Meeting I   02 juin 2022
DUART: durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy.
Future oncology (London, England)   15 novembre 2021
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer.
Clinical genitourinary cancer   17 septembre 2021
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.
JAMA oncology   04 juin 2021
KEYNOTE-799: Phase 2 trial of pembrolizumab plus platinum chemotherapy and radiotherapy for unresectable, locally advanced, stage 3 NSCLC.
2021 ASCO Annual Meeting I   28 mai 2021
TAXOMET: A Multicentric, Randomized, Phase II Study Evaluating the Combination of METFORMIN With TAXOTERE®+Metformine Placebo Versus TAXOTERE®+Metformin for the Treatment of Metastatic Hormone-refractory Prostate Cancer.
Essai Clinique (Centre Antoine Lacassagne)   04 juin 2018
P2.05-034 New 3D «All in 1» Device for Fiducial Tumor Marking: A Pilot Animal Study: Topic: RT Techniques
Abstracts from the IASLC 17th World Conference on Lung Cancer   01 janvier 2017
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}